Omnicell

What Omnicell does

Omnicell, Inc. (NASDAQ: OMCL) is a US-based healthcare technology company founded in 1992 by Randall Lipps and headquartered in Fort Worth, Texas (principal executive office), with operations across the US, UK, Germany, France, Italy, Netherlands, Australia, China, India, and the UAE. The company provides medication management automation solutions for hospitals, health systems, and specialty pharmacies, spanning automated dispensing cabinets (XT Series, Titan XT), central pharmacy robotics (XR2), IV compounding robotics (IVX Station), RFID-enabled perioperative systems (MedTrack, MedVision), and cold-chain storage (MedChill).

The technical core of the platform is OmniSphere, a HITRUST CSF i1-certified, cloud-native software workflow engine and data platform that integrates Omnicell's enterprise robotics and smart devices across care settings and connects to Epic and Cerner EHR systems via HL7/FHIR, plus DSCSA partners (TrackTraceRX, LSPedia). The product portfolio is anchored by an extensive patent estate spanning the US, Europe, China, Japan, Korea, Australia, Canada, and Singapore. Omnicell is investing in AI and machine vision through a newly opened Austin Innovation Lab and a refreshed technology leadership under CTO Perry Genova, with the stated strategic goal of enabling autonomous medication management.

Omnicell generates revenue through a mix of one-time equipment sales (automated dispensing cabinets, central pharmacy and IV compounding robots) and recurring software and services revenue, with the latter explicitly positioned as the strategic growth lever to reduce dependence on lumpy hardware cycles. Q1 2026 revenue of $310 million (+15% YoY) and service revenue of $135 million (+8% YoY) reflect this transition. Distribution is exclusively direct enterprise field sales to hospitals and health systems, with no reseller or distributor channel disclosed. The company acquired ANiGENT in 2025 and partnered with Gollmann in 2024 to broaden its automation capabilities and geographic reach.

Name

Omnicell

Legal name

Omnicell, Inc.

Website

https://omnicell.com

Company type

Public

Founded year

1992

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Omnicell is a public healthcare technology company providing medication management automation—including automated dispensing cabinets, central pharmacy robots, IV compounding robotics, and the OmniSphere cloud platform—to hospitals, health systems, and specialty pharmacies globally.

Ownership category

akta.pro rank

Product category

Pharmacy Automation and Medication Management

NAICS

Surgical and Medical Instrument Manufacturing (339112)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Medication Therapy Management (MTM) & Clinical Pharmacy Services Tools (HLACAKAH)

akta.pro secondary industry

Medication Adherence & Smart Drug Delivery (Connected Inhalers, Pens, Pill Dispensers) (HLACAPAH)

Keywords

• Pharmacy automation
• Medication management
• Automated dispensing cabinets
• Central pharmacy robots
• IV compounding systems

Headquarters

HQ city

Santa Clara

HQ country

United States

HQ region

North America

Offices18 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Supply Chain, Marketing or Sales, Operations

Revenue model

1. Automated Dispensing Cabinets: One-time equipment sales of automated dispensing cabinets (XT Series) sold to hospitals and health systems. This is the historical core of the business.
2. Central Pharmacy Robots: Sale of central pharmacy robotic systems including XR2 for medication dispensing automation.
3. Software (SaaS): Software sold to hospitals and health systems including cloud-based OmniSphere platform, MedVision, and analytics tools. The company is actively pursuing strategy to increase recurring software and services revenue to reduce dependence on one-time equipment sales.
4. Services and Technical Services: Service revenue including technical services, training, and support for installed base. Q1 2026 service revenue was $135 million, up 8% year-over-year.
5. Connected Devices: Connected smart devices including dispensing cabinets and other smart devices that integrate with the OmniSphere platform.

Pricing tiers

Go-to-market motion2 records

Distribution channels1 record

Marketing channels6 records

Core offering

Omnicell designs, manufactures, and sells automated medication management solutions to hospitals and health systems, including automated dispensing cabinets (XT Series, Titan XT), central pharmacy robots (XR2), robotic IV compounding systems (IVX Station), RFID-enabled smart devices, and the cloud-native OmniSphere software platform. The company also provides managed services (Central Pharmacy Dispensing Service, IV Compounding Service, Specialty Pharmacy Services, 340B program management) and patient engagement tools through its EnlivenHealth brand.

Product overview

Omnicell offers a unified portfolio of medication management products organized around the Autonomous Pharmacy vision — combining robotics (XR2, IVX Station, Titan XT), smart devices (XT Automated Dispensing Cabinets, XT Anesthesia Workstation, MedChill, MedTrack RFID), and intelligent software (OmniSphere cloud platform, MedVision, MedXpert, Insights) across all care settings (Inpatient: IV Room, Central Pharmacy, Points of Care; Outpatient: Specialty Pharmacy, Retail Pharmacy, Medication Adherence). The core platform is OmniSphere, a cloud-native workflow engine that unifies enterprise robotics and smart devices, providing real-time inventory visibility and analytics. Services include Central Pharmacy Dispensing Service (CPDS), IV Compounding Service (IVCS), Inventory Optimization Service, Specialty Pharmacy Services, 340B program management, and EnlivenHealth patient engagement solutions. Omnicell's Austin Innovation Lab drives next-generation AI and robotics development. The company also acquired ANiGENT in 2025 to expand its pharmacy automation capabilities.

Differentiator

Problem solved

Functional benefit

Brands

• OmniSphere: Next-generation cloud native software workflow engine and data platform for enterprise medication management
• Titan XT
• XR2
• IVX Station
• MedVision
• MedChill
• EnlivenHealth
• ANiGENT
• XT Series

Products and services

• Titan XT Automated Dispensing System Enterprise-level automated medication dispensing system (ADC) for points of care, combining proven automation with powerful intelligence to deliver enhanced medication management. Omnicell's first major automated dispensing cabinet refresh since 2017.
• OmniSphere Cloud Platform Cloud-native software workflow engine and data platform that integrates enterprise robotics and smart devices across all healthcare settings, providing real-time inventory visibility, analytics, and enterprise-wide medication control across central pharmacy, IV room, and points of care.
• XR2 Automated Central Pharmacy System

Quantifiable outcome

• Baptist Health Alabama achieved $425,000 in savings with intelligent inventory solutions
• +3 more outcomes

Named customers19 records

Segments5 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration6 records

AI capability7 records

Feature8 records

Partnerships

Six partnerships are on record, tiered minor and core.

• Evoke Pharma / EVERSANAminorStrategic or Co-development Partner · 26 August 2025Omnicell relationship with Evoke Pharma and EVERSANA expands GIMOTI access to gastro health and large GI practices through specialty pharmacy and 340B services.
• ANiGENTcoreStrategic or Co-development Partner · 1 January 2025Omnicell acquired ANiGENT, expanding its portfolio of pharmacy automation solutions and capabilities in medication management.
• Gainsight (Customer Community)minorImplementation/ SI/ Consulting Partner · 1 January 2025Gainsight provides and manages Omnicell's customer community web forum, including content moderation services.
• GollmannminorStrategic or Co-development Partner · 13 December 2024Omnicell and Gollmann joined forces to revolutionize pharmacy automation, combining complementary technologies and market presence in the pharmacy automation space.
• TrackTraceRXcoreTechnology or Integration · 9 December 2024TrackTraceRX collaboration with Omnicell launched a new pharmacy inventory tracking interface designed to support DSCSA (Drug Supply Chain Security Act) compliance and strengthen pharmacy supply chain security. The interface integrates with OmniSphere platform.
• LSPediacoreTechnology or Integration · 9 December 2024LSPedia collaboration with Omnicell provides DSCSA-compliant interfaces integrated with OmniSphere platform for pharmacy supply chain security and regulatory compliance.

Scale indicators18 records

Recent moves7 records

Expansion highlights7 records

Direct peers

• Becton, Dickinson and Company (BD): BD's Pyxis product line directly competes with Omnicell's XT automated dispensing cabinets and central pharmacy automation in the same hospital and health system accounts, making it the most direct peer in medication management.
• Capsa Healthcare: Capsa Healthcare builds automated dispensing cabinets, medication carts and pharmacy workflow solutions that overlap directly with Omnicell's XT cabinet and point-of-care dispensing portfolio.
• ScriptPro: ScriptPro provides pharmacy robotics, dispensing automation and medication management software for retail and hospital pharmacies, competing with Omnicell's central pharmacy and retail pharmacy automation offerings.
• Swisslog Healthcare: Swisslog Healthcare offers hospital pharmacy automation solutions including centralized pharmacy robots and packaging systems that compete with Omnicell's XR2 and IVX Station in inpatient pharmacy workflows.
• ARxIUM (now part of Becton Dickinson): ARxIUM's pharmacy automation solutions (central pharmacy robots and workflow software) competed directly with Omnicell's XR2 and IVX systems before being folded into BD's medication management portfolio.

Broad incumbents

• Oracle Health (formerly Cerner): Oracle Health's EHR and medication management modules integrate with hospital pharmacy workflows and compete at the software layer with OmniSphere, while also partnering via HL7/FHIR for ADCs and pharmacy automation.
• Baxter International: Baxter operates broadly across medication delivery, IV solutions and hospital pharmacy, overlapping with Omnicell's IV compounding and sterile preparation portfolio as part of a much wider medical products business.
• McKesson: As the largest pharmaceutical distributor with extensive specialty pharmacy and 340B services, McKesson competes with Omnicell's Specialty Pharmacy Services and broader medication management footprint across health system customers.

Others

• Health Robotics (now part of Omnicell-related ecosystem): Health Robotics (originally an independent IV compounding robotics vendor, whose technology traces into today's IVX/APOTECA ecosystem) is adjacent technology that historically competed with Omnicell's sterile compounding line.

Emerging players

• Talis Clinical: Talis Clinical offers IV infusion workflow and medication safety software that overlaps with Omnicell's IVX Station and IV Compounding Service in the high-acuity IV room segment.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/Omnicell
• Facebookfacebook.com/108506275911979
• LinkedInlinkedin.com/company/omnicell

Compliance8 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles14 records

Subsidiaries1 record

Funding overview

Funding rounds3 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A6 records

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Omnicell